Correlation Between IShares Healthcare and Franklin Genomic
Can any of the company-specific risk be diversified away by investing in both IShares Healthcare and Franklin Genomic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares Healthcare and Franklin Genomic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between iShares Healthcare ETF and Franklin Genomic Advancements, you can compare the effects of market volatilities on IShares Healthcare and Franklin Genomic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares Healthcare with a short position of Franklin Genomic. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares Healthcare and Franklin Genomic.
Diversification Opportunities for IShares Healthcare and Franklin Genomic
0.81 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between IShares and Franklin is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding iShares Healthcare ETF and Franklin Genomic Advancements in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Franklin Genomic Adv and IShares Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iShares Healthcare ETF are associated (or correlated) with Franklin Genomic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Franklin Genomic Adv has no effect on the direction of IShares Healthcare i.e., IShares Healthcare and Franklin Genomic go up and down completely randomly.
Pair Corralation between IShares Healthcare and Franklin Genomic
Considering the 90-day investment horizon iShares Healthcare ETF is expected to generate 0.63 times more return on investment than Franklin Genomic. However, iShares Healthcare ETF is 1.59 times less risky than Franklin Genomic. It trades about 0.05 of its potential returns per unit of risk. Franklin Genomic Advancements is currently generating about 0.01 per unit of risk. If you would invest 5,215 in iShares Healthcare ETF on November 19, 2024 and sell it today you would earn a total of 878.00 from holding iShares Healthcare ETF or generate 16.84% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
iShares Healthcare ETF vs. Franklin Genomic Advancements
Performance |
| Timeline |
| iShares Healthcare ETF |
| Franklin Genomic Adv |
IShares Healthcare and Franklin Genomic Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with IShares Healthcare and Franklin Genomic
The main advantage of trading using opposite IShares Healthcare and Franklin Genomic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares Healthcare position performs unexpectedly, Franklin Genomic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Franklin Genomic will offset losses from the drop in Franklin Genomic's long position.| IShares Healthcare vs. iShares Financials ETF | IShares Healthcare vs. iShares Consumer Discretionary | IShares Healthcare vs. iShares Industrials ETF | IShares Healthcare vs. iShares Consumer Staples |
| Franklin Genomic vs. Artec Consulting Corp | Franklin Genomic vs. Franklin Disruptive Commerce | Franklin Genomic vs. Photronics | Franklin Genomic vs. Global X Genomics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Stocks Directory Find actively traded stocks across global markets | |
| CEOs Directory Screen CEOs from public companies around the world |